Fig.3.

Current global initiatives focused on AD CSF biomarkers. Involvement of worldwide consortia in the standardization of CSF biomarker analysis at the level of the assay, the sample, and the laboratory. Grey box: the need for the future. ADNI, Alzheimer’s disease neuroimaging initiative; AIBL, The Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing; CAMD, Coalition Against Major Diseases; GBSC, Global Biomarker Standardization Initiative; IFCC, International Federation of Clinical Chemistry; JPND, EU Joint Programme - Neurodegenerative Disease Research (JPND); QC, quality control; SOP, standard operating procedure.